Article

FDA to review Gilead cystic fibrosis drug

A Gilead Sciences Inc. investigational antibiotic for cystic fibrosis patients with deadly infections will be reviewed by an FDA panel Dec. 10. (GILD)

Last Modified : October 26th, 2009
Filed under : Uncategorized
Navigate : Previous post / Next post

Comments (No comments)

Comments are closed for this post.

Post a comment

Comments are closed for this post.